Profile

About Ian

Ian Jenkins is chief science officer at GATC Health in Irvine, California, a company that applies its artificial intelligence platform, Operon, to drug discovery and development and to the assessment of therapeutic assets before clinical testing. Jenkins's background bridges laboratory genetics and computational prediction. Earlier roles listed by the company include laboratory scientist posts in genetics research at Midwestern and in epigenetic research at the Davidson Lab, a junior vice president role in clinical development for precision medicine at Orn, and co-founding Unprescribed, a venture focused on computational predictive genetic expression.
Published research

Publications

1 article

Research network

Co-authors

5 collaborators